title: Intestinal transplantation: a review.
abstract: Parenteral nutrition is a life-saving therapy for patients with intestinal failure. Intestinal transplantation is now recognized as a treatment for patients who develop complications of parenteral nutrition and in whom attempts at intestinal rehabilitation have failed. Patients with parenteral nutrition related liver disease will require a liver graft typically part of a multivisceral transplant. Isolated intestinal transplants are more commonly performed in adults while multivisceral transplants are most commonly performed in infants. Isolated intestinal transplants have the best short-term outcome, with over 80 % survival at 1 year. Patients requiring multivisceral transplants have a high rate of attrition with a 1 year survival less than 70 %. Prognostic factors for a poor outcome include patient hospitalization at the time of transplant and donor age greater than 40 years while systemic sepsis and acute rejection are the major determinant of early postoperative outcome. For patients surviving the first year the outcome of transplantation of the liver in addition to intestine affords some survival advantage though long-term outcome does not yet match other abdominal organs. Outcomes for intestinal retransplantation are poor as a result of immunology and patient debility. Overall intestinal transplantation continues to develop and is a clear indication with cost and quality of life advantages in patients with intestinal failure that do not remain stable on parenteral nutrition.
authors.affiliation: Georgetown Transplant Institute, Main Hospital Building, Washington, DC 20007, USA. csdesai@gmail.com
authors.forename: Chirag Sureshchandra
authors.initials: CS
authors.lastname: Desai
authors.forename: Khalid Mahmood
authors.initials: KM
authors.lastname: Khan
authors.forename: Raffaele
authors.initials: R
authors.lastname: Girlanda
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Fishbein
mesh_terms: D000328:Adult; D018450:Disease Progression; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007410:Intestinal Diseases / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D007421:Intestine, Small / Q000637:transplantation*; D008297:Male; D016377:Organ Transplantation / Q000009:adverse effects / Q000379:methods*; D010289:Parenteral Nutrition, Total / Q000009:adverse effects* / Q000379:methods; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome